# Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia

> **NCT06918054** · PHASE4 · RECRUITING · sponsor: **Ain Shams University** · enrollment: 42 (estimated)

## Conditions studied

- Leukaemia (Acute)
- Acute Lymphoblastic Leukemia

## Interventions

- **DIETARY_SUPPLEMENT:** Dietary modification
- **DIETARY_SUPPLEMENT:** Supplementation of omega 3 fatty acids

## Key facts

- **NCT ID:** NCT06918054
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-17
- **Primary completion:** 2025-05
- **Final completion:** 2025-08
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06918054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06918054, "Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06918054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*